sacituzumab tirumotecan (SKB-264) is under development for the treatment of ovarian epithelial cancer, gastric adenocarcinoma, triple negative breast cancer, endometrial carcinoma, HER2 negative ...

Background Endometrial cancer is the most common gynecologic malignancy in developed countries. Trop-2 is a glycoprotein involved in cellular signal transduction and is differentially ...

adenocarcinoma of the cervix and adenocarcinoma of the endometrium, leiomyosarcoma, urothelial carcinoma, triple negative breast cancer, non-squamous non-small cell lung cancer, fallopian tube cancer, ...

If managed expectantly, it frequently progresses to endometrial carcinoma, rates of which are increasing dramatically worldwide. However, the established treatment for endometrial hyperplasia ...

Endometrial large-cell neuroendocrine carcinoma admixed with a high-grade serous (HGS) adenocarcinoma is extremely rare with only one reported case in the literature. We present the second reported ...

DOCTOR, A RECENT REPORT SHOWS ENDOMETRIAL CANCER IS ON THE RISE. SO, DO YOU KNOW THE MOST COMMON SYMPTOMS ASSOCIATED WITH THE DISEASE? WOMEN IN THEIR MENOPAUSAL YEARS NEED TO WATCH OUT FOR VAGINAL ...

The International Federation of Gynecology and Obstetrics (FIGO) staging systems for vulva, cervix, endometrium, and sarcomas have been revised for the first time in over a decade. The purpose of ...

Four patients had genitourinary cancers (renal cell carcinoma, prostate adenocarcinoma and urothelial carcinoma) and three patients had cervical squamous cell carcinoma, clear cell endometrial ...

It also summarizes the established molecules with FTO-inhibiting activity. Given the extensive impact of FTO on both physiology and pathophysiology, this overview provides illustrative insights into ...